This inventor holds 1 USPTO granted patent. Top assignee: Masarykova Univerzita. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Jana Kotaskova: Innovator in Chronic Lymphocytic Leukemia Research
Introduction
Jana Kotaskova is a prominent inventor based in Brno, Czech Republic. She has made significant contributions to the field of medical research, particularly in the diagnosis and prognosis of B-cell chronic lymphocytic leukemia (CLL). Her innovative work has the potential to improve patient outcomes through advanced diagnostic methods.
Latest Patents
Jana Kotaskova holds a patent titled "Method of determination of diagnosis and prognosis in patients with B-cell chronic lymphocytic leukemia and oligonucleotides for use in this method." This invention provides a method for determining the diagnosis and prognosis of CLL from biological samples collected from patients. The method focuses on assessing the status of the Wnt/PCP signaling pathway, which is significantly up-regulated in B-lymphocytes of CLL patients. The invention also includes suitable oligonucleotides for use in determining the expression of the signaling pathway components.
Career Highlights
Jana Kotaskova is affiliated with Masaryk University, where she conducts her research and develops her innovative methods. Her work has garnered attention for its potential to revolutionize the way CLL is diagnosed and treated. With her expertise, she continues to contribute to the advancement of medical science.
Collaborations
Jana has collaborated with notable colleagues, including Vitezslav Bryja and Pavel Krejci. These partnerships have enhanced her research efforts and expanded the impact of her work in the field of chronic lymphocytic leukemia.
Conclusion
Jana Kotaskova is a trailblazer in the realm of medical innovation, particularly in the diagnosis of chronic lymphocytic leukemia. Her patented methods and collaborative efforts are paving the way for improved patient care and outcomes.